Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126164321 | 12616432 | 1 | I | 2012 | 20160720 | 20160802 | 20160802 | EXP | CN-ELI_LILLY_AND_COMPANY-CN201607008892 | ELI LILLY AND CO | 72.00 | YR | M | Y | 62.50000 | KG | 20160801 | CN | CN | CN |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126164321 | 12616432 | 1 | PS | HUMULIN R | INSULIN HUMAN | 1 | Subcutaneous | 16 U, QD | 18780 | 16 | IU | INJECTION | QD | ||||||
| 126164321 | 12616432 | 2 | SS | HUMULIN R | INSULIN HUMAN | 1 | Subcutaneous | 8 U, QD | 18780 | 8 | IU | INJECTION | QD | ||||||
| 126164321 | 12616432 | 3 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 24 U, QD | C490006D | 0 | 24 | IU | INJECTION | QD | |||||
| 126164321 | 12616432 | 4 | SS | HUMALOG | INSULIN LISPRO | 1 | Subcutaneous | 8 U, QD | C490006D | 0 | 8 | IU | INJECTION | QD | |||||
| 126164321 | 12616432 | 5 | C | ONGLYZA | SAXAGLIPTIN HYDROCHLORIDE | 1 | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126164321 | 12616432 | 1 | Diabetes mellitus |
| 126164321 | 12616432 | 3 | Diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126164321 | 12616432 | OT |
| 126164321 | 12616432 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126164321 | 12616432 | Blindness unilateral | |
| 126164321 | 12616432 | Blood glucose decreased | |
| 126164321 | 12616432 | Blood glucose increased | |
| 126164321 | 12616432 | Cataract | |
| 126164321 | 12616432 | Diabetic complication | |
| 126164321 | 12616432 | Diabetic vascular disorder | |
| 126164321 | 12616432 | Drug dose omission | |
| 126164321 | 12616432 | Memory impairment | |
| 126164321 | 12616432 | Retinal haemorrhage | |
| 126164321 | 12616432 | Visual acuity reduced |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126164321 | 12616432 | 1 | 2012 | 2013 | 0 | |
| 126164321 | 12616432 | 2 | 2012 | 2013 | 0 | |
| 126164321 | 12616432 | 3 | 2013 | 0 | ||
| 126164321 | 12616432 | 4 | 2013 | 0 |